The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds

被引:95
作者
Stover, J. [1 ]
Johnson, P. [2 ]
Zaba, B. [3 ]
Zwahlen, M. [4 ]
Dabis, F. [5 ]
Ekpini, R. E. [6 ]
机构
[1] Futures Inst, Glastonbury, CT USA
[2] US Bur Census, Washington, DC 20233 USA
[3] London Sch Hyg & Trop Med, London WC1, England
[4] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland
[5] Univ Victor Segalen, ISPED, Bordeaux, France
[6] UNICEF, New York, NY USA
关键词
D O I
10.1136/sti.2008.029868
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The approach to national and global estimates of HIV/AIDS used by UNAIDS starts with estimates of adult HIV prevalence prepared from surveillance data using either the Estimation and Projection Package (EPP) or the Workbook. Time trends of prevalence are transferred to Spectrum to estimate the consequences of the HIV/AIDS epidemic, including the number of people living with HIV, new infections, AIDS deaths, AIDS orphans, treatment needs and the impact of treatment on survival. Methods: The UNAIDS Reference Group on Estimates, Modelling and Projections regularly reviews new data and information needs and recommends updates to the methodology and assumptions used in Spectrum. The latest update to Spectrum was used in the 2007 round of global estimates. Results: Several new features have been added to Spectrum in the past two years. The structure of the population was reorganised to track populations by HIV status and treatment status. Mortality estimates were improved by the adoption of new approaches to estimating non-AIDS mortality by single age, and the use of new information on survival with HIV in non-treated cohorts and on the survival of patients on antiretroviral treatment (ART). A more detailed treatment of mother-to-child transmission of HIV now provides more prophylaxis and infant feeding options. New procedures were implemented to estimate the uncertainty around each of the key outputs. Conclusions: The latest update to the Spectrum program is intended to incorporate the latest research findings and provide new outputs needed by national and international planners.
引用
收藏
页码:I24 / I30
页数:7
相关论文
共 47 条
[1]  
BEERS HS, 1945, REC AM I ACTUARIES 1, V34, P59
[2]   Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage [J].
Boerma, JT ;
Stanecki, KA ;
Newell, ML ;
Luo, C ;
Beusenberg, M ;
Garnett, GP ;
Little, K ;
Calleja, JG ;
Crowley, S ;
Kim, JY ;
Zaniewski, E ;
Walker, N ;
Stover, J ;
Ghys, PD .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2006, 84 (02) :145-150
[3]  
Bourgeois A, 2005, ANTIVIR THER, V10, P335
[4]  
Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2
[5]  
BRINKHOF MWG, B WHO IN PRESS
[6]  
Brown T., 2008, SEX TRANSM INFECT S1, V84, P5
[7]   Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort [J].
Calmy, Alexandra ;
Pinoges, Lorextu ;
Szumilin, Elisabeth ;
Zachariah, Rony ;
Ford, Nathan ;
Ferradini, Laurent .
AIDS, 2006, 20 (08) :1163-1169
[8]   Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa [J].
Coetzee, D ;
Hildebrand, K ;
Boulle, A ;
Maartens, G ;
Louis, F ;
Labatala, V ;
Reuter, H ;
Ntwana, N ;
Goemaere, E .
AIDS, 2004, 18 (06) :887-895
[9]  
Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834
[10]  
Dabis F, 2005, AIDS, V19, P309